Mahdi Seify | Public Health | Innovative Research Award

Innovative Research Award

Mahdi Seify
Affiliation University of Northampton
Country United Kingdom
Scopus ID 58026194200
Documents 3
Citations 26
h-index 2
Subject Area Public Health
Event Global Diseases Research Awards

Mahdi Seify is a researcher and academic affiliated with the University of Northampton in the United Kingdom. His documented work connects artificial intelligence, analytics, healthcare applications, project management, and information systems. His research record includes peer-reviewed healthcare analytics research and a 2026 Elsevier chapter concerning artificial intelligence and brain tumour detection.[2]

Abstract

Mahdi Seify is an academic researcher associated with the University of Northampton whose work intersects artificial intelligence, business analytics, healthcare, information systems, and project management. His documented research includes analytical methods for understanding patient experience and general practitioner classification, alongside more recent work applying artificial intelligence and machine learning to biomedical diagnosis. His institutional profile identifies research interests in AI-enhanced management control systems, predictive analytics, AI governance, workflow orchestration, human-in-the-loop automation, and digital technologies. His publication record includes peer-reviewed healthcare research and an Elsevier book chapter addressing AI-assisted brain tumour detection, providing a multidisciplinary basis for recognition within an innovative research context.[2]

Keywords

Mahdi Seify; public health; artificial intelligence; business analytics; healthcare analytics; predictive analytics; machine learning; patient experience; biomedical research; brain tumour detection; AI governance; information systems; innovative research; University of Northampton; Global Diseases Research Awards.[1]

Introduction

Mahdi Seify serves at the University of Northampton, where institutional information identifies him as a Senior Lecturer in Project Management and Business Analytics. His academic activities span analytics, systems thinking, digital transformation, and applied research. His documented healthcare research demonstrates collaboration across business systems, operations, and public-health-oriented applications.[3]

Research Profile

Seify’s institutional research profile describes interests including AI-enhanced management control systems, predictive and causal modelling, AI readiness and governance, workflow orchestration, and human-in-the-loop automation. The Institute of Analytics separately describes his work across artificial intelligence, data analytics, business strategy, predictive analytics, Internet of Things technologies, and system dynamics.[2]

Research Contributions

His documented contributions include healthcare-oriented sentiment analysis, analytical classification of general practitioner feedback, and applications of artificial intelligence to biomedical research. Institutional descriptions also identify predictive analytics, AI governance, and digital technologies as continuing research themes. These areas demonstrate an interdisciplinary connection between computational methods, organisational systems, and healthcare applications.[2]

Publications

Seify’s documented publications include research on patient experience and healthcare classification, as well as a recent Elsevier chapter addressing artificial intelligence and machine learning in brain tumour detection. His institutional profile also records earlier works concerning fraud detection, supply-chain machine learning, information security, and emergency response systems. [3]

Research Impact

The supplied research metrics record three documents, 26 citations, and an h-index of 2 for the specified Scopus profile. These figures describe bibliometric activity associated with the supplied author identifier and should be interpreted according to the coverage and updating practices of Scopus. They provide quantitative context rather than a comprehensive assessment of research quality.[1]

Award Suitability

For an Innovative Research Award profile, Seify’s documented work provides several relevant areas for consideration, including healthcare analytics, artificial intelligence, machine learning, and biomedical applications. His 2023 healthcare study and 2026 Elsevier chapter demonstrate research activity connecting computational approaches with health-related problems. Final award assessment remains subject to the event’s stated review criteria.[4]

Conclusion

Mahdi Seify’s documented academic profile combines artificial intelligence, analytics, healthcare applications, and information systems. His publications demonstrate research addressing patient experience and biomedical diagnosis, while institutional profiles identify broader interests in predictive analytics and responsible AI. The supplied bibliometric information provides additional quantitative context for this academic recognition profile.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Mahdi Seify, Author ID 58026194200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58026194200
  2. Pandey, A. R., Seify, M., Okonta, U., & Hosseinian-Far, A. (2023). Advanced Sentiment Analysis for Managing and Improving Patient Experience: Application for General Practitioner (GP) Classification in Northamptonshire. International Journal of Environmental Research and Public Health, 20(12), 6119.
    https://doi.org/10.3390/ijerph20126119
  3. Seify, M., Jalali Moghaddam, M., Sarwar, D., Hansani, W. K., Thiwanthika, K. P. D., Frahmand, A., Osadugba, T., Dang, T. D., Ghashami, H., & Hosseinian Far, A. (2026). Revolutionising Brain Tumour Detection: Integrating AI and Machine Learning for Enhanced Diagnostic Accuracy and Healthcare Efficiency. In Cognitive and Meta Learning Strategies in Biomedical Research and Healthcare. Elsevier.
    https://doi.org/10.1016/B978-0-443-40379-8.00009-0
  4. Global Diseases Research Awards. (n.d.). Global Diseases Research Awards official website.
    https://globaldiseases.org/

 

Muzaffer Sanci | Epidemiology | Innovative Research Award

Innovative Research Award

Muzaffer Sanci — İzmir Şehir Hastanesi, Turkey

Muzaffer Sanci
Affiliation İzmir Şehir Hastanesi
Country Turkey
Scopus ID 6508123738
Documents 165
Citations 1,526
h-index 21
Subject Area Epidemiology
Event Global Diseases Research Awards

Muzaffer Sanci is a researcher affiliated with İzmir Şehir Hastanesi in Turkey whose documented scholarly profile is associated with epidemiology. The recognition presented here concerns the Innovative Research Award within the Global Diseases Research Awards, emphasizing research activity, publication output, citation visibility, and potential relevance to contemporary disease research.[1]

Abstract

Muzaffer Sanci’s academic profile indicates sustained research activity in epidemiology, supported by 165 indexed documents, 1,526 citations, and an h-index of 21. His affiliation with İzmir Şehir Hastanesi, Turkey, places the profile within a clinical and public-health environment relevant to disease investigation. The Innovative Research Award recognizes research-oriented contributions where methodological development, evidence generation, and practical relevance may support advances in health science. The available bibliometric indicators provide a quantitative description of scholarly visibility, while interpretation of individual contributions should consider publication quality, authorship roles, research methods, and relevance to global disease challenges and population health priorities.[1]

Keywords

Muzaffer Sanci; epidemiology; innovative research; disease research; clinical research; bibliometrics; Scopus; Global Diseases Research Awards; Turkey.[1]

Introduction

Epidemiology examines the distribution, determinants, and control of health-related conditions across populations. Its methods support disease surveillance, risk assessment, prevention, and evaluation of interventions. Researchers working in clinical and population-health settings can contribute evidence that connects observed health patterns with diagnostic, therapeutic, and public-health decision-making and policy development.[2]

Research Profile

The supplied Scopus information records 165 documents, 1,526 citations, and an h-index of 21 for Muzaffer Sanci. These indicators describe indexed publication activity and citation impact, but they do not independently establish research quality. Bibliometric measures should therefore be interpreted alongside study design, originality, collaboration, and substantive contribution to knowledge and practice.[1]

Research Contributions

An epidemiology-focused research profile may encompass investigation of disease patterns, risk factors, clinical outcomes, prevention strategies, and population-level evidence. For award assessment, relevant contributions can be examined through documented publications, methodological approaches, datasets, collaborations, and the extent to which findings address clearly defined scientific or healthcare problems in practice.[2]

Publications

The supplied profile identifies 165 Scopus-indexed documents but does not provide a complete publication list or individual article metadata. Consequently, this article does not attribute specific findings to particular papers without verification. Publication assessment should use the author’s indexed record, including titles, journals, citation counts, authorship position, and persistent identifiers.[1]

Research Impact

A citation count of 1,526 and an h-index of 21 indicate measurable scholarly visibility within the supplied Scopus record. Such indicators can help contextualize research influence, while citation practices vary among disciplines. A balanced assessment should also consider clinical relevance, reproducibility, methodological rigor, collaboration, and evidence of use beyond citation counts.[1][3]

Award Suitability

The Innovative Research Award is potentially aligned with an epidemiology researcher when documented work demonstrates originality, methodological advancement, meaningful evidence generation, or practical relevance. Muzaffer Sanci’s supplied publication and citation indicators provide contextual evidence of research activity, while final award suitability should depend on independently verified scholarly contributions and eligibility criteria for recognition.[5]

Conclusion

Muzaffer Sanci’s supplied academic record presents an established epidemiology-oriented research profile, with 165 documents, 1,526 citations, and an h-index of 21. These metrics support recognition of sustained scholarly activity, but they should be considered with qualitative evidence. The Innovative Research Award assessment should therefore combine bibliometric information with verified research contributions and documented scientific relevance.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Muzaffer Sanci, Author ID 6508123738. Scopus.
    https://www.scopus.com/pages/authors/6508123738
  2. Özuyar Şimşek, G., Uzunlar, Ö., Özen, S., Çandar, T., Sancı, M., & Duman, E. D. (2026). Investigation of the effect of TNF-α levels on infertility duration and infertility characteristics in endometriosis patients presenting with infertility complaints. BMC Women’s Health, 26(1).
    https://doi.org/10.1186/s12905-026-04586-w
  3. Özen, S., Güner Özen, E., Özuyar Şimşek, G., Arzik, A. O., Karaoğlu, S., Akdemir, C., & Sanci, M. (2026). HPV persistence and CIN2+ detection in women with normal cytology and non-16/18 high-risk HPV positivity. BMC Women’s Health.
    https://doi.org/10.1186/s12905-026-04278-5
  4. Korkmaz, O., Aydemir, I., Turkoz Uluer, E., Sancı, M., Diniz, G., Sayhan, S., & İnan, S. (2026). Stage-dependent expression and nuclear localization of EZH2 in endometrial carcinogenesis: Evidence from cell lines and human tissues. Journal of Molecular Histology, 57, Article 262.
    https://doi.org/10.1007/s10735-026-10930-z
  5. Özen, S., Güner Özen, E., & Sancı, M. (2026). Preoperative imaging for nodal assessment in endometrial carcinoma: A comparative study of MRI and 18F-FDG PET/CT across risk groups. Medicina, 62(7), 1418.
    https://doi.org/10.3390/medicina62071418

 

Werner Mohl | Epidemiology | Innovative Research Award

Innovative Research Award

Werner Mohl
Medical University of Vienna
Werner Mohl
Affiliation Medical University of Vienna
Country Austria
Scopus ID 21641111500
Documents 113
Citations 1,315
h-index 20
Subject Area Epidemiology
Event Global Diseases Research Awards
ORCID 0000-0002-4894-0494

Werner Mohl is a researcher affiliated with the Medical University of Vienna whose scholarly activities have contributed to biomedical and epidemiological investigations through a sustained publication record. His academic profile demonstrates measurable scientific influence through peer-reviewed outputs, citation performance, and interdisciplinary engagement. The present article evaluates his research profile in the context of the Innovative Research Award associated with the Global Diseases Research Awards program.[1]

Abstract

This article presents an academic overview of Werner Mohl and evaluates the scholarly characteristics supporting consideration for the Innovative Research Award. Affiliated with the Medical University of Vienna, Mohl has established a publication portfolio comprising 113 indexed documents and 1,315 citations with an h-index of 20. His research activities demonstrate continued engagement in biomedical and epidemiological investigations while contributing to scientific literature through collaborative and peer-reviewed scholarship. Bibliometric indicators suggest sustained research productivity and measurable academic visibility. These achievements collectively provide a foundation for assessing scientific influence, knowledge dissemination, and potential recognition within international research award frameworks.[1]

Keywords

Werner Mohl; Medical University of Vienna; Epidemiology; Biomedical Research; Scientific Publications; Citation Analysis; Research Impact; Academic Recognition; Global Diseases Research Awards; Innovative Research Award.

Introduction

Recognition through scientific awards generally reflects the quality, consistency, and influence of a researcher’s contributions within a specific field. Werner Mohl’s academic profile indicates sustained participation in scientific research, publication activity, and scholarly communication. Such characteristics provide an important basis for evaluating his professional achievements within the context of international academic recognition programs and competitive award assessments.[4]

Research Profile

According to available bibliometric indicators, Werner Mohl has authored or co-authored 113 scholarly documents indexed in Scopus. These publications have accumulated 1,315 citations, resulting in an h-index of 20. Such metrics indicate a research portfolio characterized by sustained productivity and citation visibility, suggesting that a substantial number of publications have contributed to ongoing academic discourse and scientific advancement.[3]

Research Contributions

Mohl’s research contributions are associated with biomedical and epidemiological investigations that support evidence generation and scientific understanding within health-related disciplines. His scholarly work demonstrates engagement with topics relevant to disease mechanisms, clinical outcomes, and translational applications. Through collaborative publications and peer-reviewed dissemination, his research has contributed to the broader body of scientific knowledge available to researchers and healthcare professionals.[2]

Publications

The publication record associated with Werner Mohl reflects long-term engagement in scientific communication through peer-reviewed articles and collaborative research outputs. Publication activity serves as an indicator of knowledge dissemination and scholarly participation. The breadth of documented research contributions demonstrates ongoing involvement in advancing scientific understanding while supporting the exchange of evidence-based findings within the international academic community.[5]

Research Impact

Research impact may be assessed through citation performance, publication visibility, and scholarly influence. With 1,315 citations and an h-index of 20, Mohl’s academic profile demonstrates measurable engagement from the scientific community. These indicators suggest that multiple publications have been referenced by subsequent studies, reflecting continued relevance and contribution to ongoing scientific discussions and evidence development.[1]

Award Suitability

Assessment for the Innovative Research Award may consider factors including publication productivity, citation influence, research quality, and contribution to scientific advancement. Werner Mohl’s documented scholarly record demonstrates characteristics commonly associated with academic recognition. His bibliometric performance, institutional affiliation, and continued contribution to research activities collectively support consideration for distinction within the Global Diseases Research Awards framework.[1]

Conclusion

Werner Mohl’s academic profile reflects sustained scholarly productivity, measurable citation impact, and continued participation in biomedical and epidemiological research. Available indicators suggest a well-established research presence supported by peer-reviewed publications and scientific engagement. Based on the documented evidence, his professional achievements align with criteria frequently considered in international research award evaluations and academic recognition initiatives.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Werner Mohl, Author ID 21641111500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=21641111500
  2. Global Diseases Research Awards. (n.d.). Award information and recognition framework.
    https://globaldiseases.org/
  3. Mohl, W., Spitzer, E., Mader, R. M., Wagh, V., Nguemo, F., Milasinovic, D., Jusić, A., Khazen, C., Szodorai, E., Birkenberg, B., Lubec, G., Hescheler, J., & Serruys, P. W. (2018). Acute molecular effects of pressure-controlled intermittent coronary sinus occlusion in patients with advanced heart failure. ESC Heart Failure, 5(5), 878–886.
    https://doi.org/10.1002/ehf2.12354
  4. Wagh, V., Nguemo, F., Kiseleva, Z., Mader, R. M., Hescheler, J., & Mohl, W. (2023). Circulating microRNAs and cardiomyocyte proliferation in heart failure patients related to 10-year survival. ESC Heart Failure, 10(6), 3921–3932. https://doi.org/10.1002/ehf2.14516
  5. Mohl, W., Kiseleva, Z., Jusić, A., Bruckner, M., & Mader, R. M. (2023). Signs and signals limiting myocardial damage using PICSO: A scoping review decoding paradigm shifts toward a new encounter. Frontiers in Cardiovascular Medicine, 10, 1030842. https://doi.org/10.3389/fcvm.2023.1030842

Anna Mainka | Antimicrobial Resistance | Innovative Research Award | 2229

Innovative Research Award

Anna Mainka
Silesian University of Technology, Poland
Innovative Research Award
Affiliation Silesian University of Technology
Country Poland
Scopus ID 57062991800
Documents 40
Citations 901
h-index 19
Subject Area Antimicrobial Resistance
Event Global Diseases Research Awards
ORCID 0000-0002-2499-1764

Anna Mainka is a researcher affiliated with Silesian University of Technology whose published work addresses environmental health, indoor air quality, airborne contaminants, and antimicrobial resistance related studies. Her scholarly profile includes multidisciplinary investigations on environmental exposure and public health assessment through peer-reviewed publications.[1]

Abstract

This academic recognition article summarizes research activities associated with Anna Mainka and her documented publication record. Research output demonstrates continuing work involving environmental exposure assessment, microbial aerosols, indoor environmental quality, and pollution-related health analysis. Existing studies indicate practical relevance in healthcare and public environmental monitoring applications.[2]

Keywords

Antimicrobial resistance, environmental health, indoor air quality, bacterial aerosols, exposure assessment, healthcare environments, atmospheric pollutants, environmental monitoring.

Introduction

Environmental exposure and antimicrobial resistance have become important interdisciplinary research topics. Studies connecting pollutants and microbial behavior contribute to improved understanding of public health conditions and environmental risk assessment. Contemporary investigations increasingly focus on healthcare environments and urban exposure patterns.[3]

Research Profile

Anna Mainka has documented publications and collaborative investigations focused on air quality assessment, exposure science, and microbiological analysis. The researcher profile indicates publication activity across international journals and multidisciplinary research areas with measurable citation performance.[1]

Research Contributions

Research contributions include studies on bacterial aerosols, particulate matter exposure, healthcare environmental quality, and indoor pollution monitoring. Several investigations evaluate pollutant exposure effects and environmental health risks using observational and applied methodologies.[4]

Publications

Published research associated with Anna Mainka demonstrates sustained contributions in environmental and atmospheric science. Research themes include healthcare microbiology, bacterial aerosols, particulate matter exposure, ventilation studies, and environmental quality assessment. Published work reflects collaborative studies across healthcare and environmental contexts with measurable scholarly influence.[5]

Research Impact

Publication metrics and citation indicators suggest continuing scholarly visibility and research engagement. Citation activity and interdisciplinary collaboration demonstrate relevance within environmental health and microbial exposure research communities.[2]

Award Suitability

The documented publication profile and environmental research activity support consideration for academic recognition associated with innovation and applied research impact. Scholarly output aligns with the interdisciplinary objectives commonly considered within research award evaluations.

Conclusion

Available publication records indicate continuing research activity and measurable scholarly contribution within environmental and antimicrobial research domains. The research profile reflects sustained publication productivity and collaboration across scientific disciplines.

References

  1. Kauch, K., Mainka, A., & Brągoszewska, E. (2026). Airborne antibiotic-resistant bacteria—Challenge for healthcare environments. Atmosphere, 17(6).https://doi.org/10.3390/atmos17060617
  2. Mainka, A., & Żak, M. (2022). Synergistic or antagonistic health effects of long and short-term exposure to ambient NO₂ and PM2.5: A review. International Journal of Environmental Research and Public Health, 19(21).https://doi.org/10.3390/ijerph192114079
  3. Mainka, A. (2021). Preschool children health impacts from indoor exposure to PM2.5 and metals. Environment International, 159.https://doi.org/10.1016/j.envint.2021.107062
  4. Brągoszewska, E., & Mainka, A. (2024). Bacterial aerosol in ambient air—A review study. Applied Sciences, 14(18).https://doi.org/10.3390/app14188250
  5. Kozielska, B., Mainka, A., Żak, M., Kaleta, D., & Mucha, W. (2020). Indoor air quality in residential buildings in Upper Silesia, Poland. Building and Environment, 177.https://doi.org/10.1016/j.buildenv.2020.106914

Swati Jayaram | Medicine | Best Researcher Award

Best Researcher Award

Swati Jayaram
The Ohio State University

Swati Jayaram
Affiliation The Ohio State University
Country India
Scopus ID 57966951000
Documents 4
Citations 1
h-index 1
Subject Area Medicine
Event Global Diseases Research Awards

The Best Researcher Award recognizes scholarly achievement, research productivity, and meaningful contributions to scientific advancement. Swati Jayaram of The Ohio State University has developed an academic profile within the field of medicine through peer-reviewed publications and participation in scientific research activities. Her documented scholarly record demonstrates engagement with evidence-based investigation and knowledge dissemination within the biomedical sciences.[1]

Abstract

Swati Jayaram is affiliated with The Ohio State University and has contributed to the field of medicine through scholarly publications and academic research activities. Her documented research profile reflects participation in scientific investigations that support evidence-based understanding and clinical knowledge development. Available bibliometric indicators demonstrate a developing publication record with measurable citation activity. The Best Researcher Award recognizes individuals whose academic efforts contribute to scientific communication, research quality, and professional advancement. Based on available scholarly metrics and publication records, her work represents ongoing engagement in medical research and supports broader objectives associated with innovation, scientific inquiry, and academic excellence within healthcare-related disciplines.[1]

Keywords

Medicine, Medical Research, Academic Excellence, Scientific Publications, Healthcare Research, Evidence-Based Medicine, Scholarly Impact, Research Productivity, Best Researcher Award, Global Diseases Research Awards.

Introduction

Academic recognition programs play an important role in highlighting research achievements and encouraging continued scientific advancement. The Best Researcher Award acknowledges individuals who demonstrate commitment to scholarly investigation, publication quality, and professional contributions that strengthen knowledge development across scientific disciplines and healthcare-related research environments.[2]

Research Profile

Swati Jayaram is associated with The Ohio State University and maintains a documented research presence within the medical sciences. Bibliometric information available through Scopus indicates four indexed publications, one citation, and an h-index of one, reflecting an emerging scholarly profile supported by peer-reviewed academic contributions.[1]

Research Contributions

Research contributions associated with Swati Jayaram demonstrate participation in scientific inquiry relevant to medicine and healthcare. Through publication activities and collaboration within academic environments, her work contributes to the dissemination of knowledge, supports evidence-based understanding, and strengthens the broader framework of medical research and scholarly communication.[1]

Publications

The publication record indexed under the Scopus author profile demonstrates engagement with peer-reviewed scholarly dissemination. Publications contribute to academic visibility, facilitate scientific discussion, and provide measurable outputs that support the evaluation of research performance. Such outputs remain important indicators of sustained participation in scholarly activities.[1]

Research Impact

Research impact is commonly assessed through publication metrics, citation performance, and scholarly visibility. Available indicators associated with Swati Jayaram suggest developing influence within the academic literature. Citation activity, although limited in quantity, demonstrates that published work has entered the scientific record and contributed to ongoing scholarly engagement.[1]

Award Suitability

The Best Researcher Award evaluates research productivity, academic commitment, publication quality, and professional contributions. Based on documented scholarly activities, Swati Jayaram demonstrates characteristics aligned with the objectives of academic recognition programs. Her participation in medical research and scientific publication supports consideration within award frameworks focused on research excellence and scholarly achievement.[2]

Conclusion

Swati Jayaram’s academic profile reflects involvement in medical research, peer-reviewed publication, and scholarly communication. Her documented contributions, supported by indexed research outputs and citation activity, demonstrate engagement with scientific advancement. These characteristics align with the principles recognized by the Best Researcher Award and highlight ongoing participation in academic research initiatives.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Swati Jayaram, Author ID 57966951000. Scopus.https://www.scopus.com/authid/detail.uri?authorId=57966951000
  2. Global Diseases Research Awards. (n.d.). Best Researcher Award and recognition framework.https://globaldiseases.org/
  3. Gillespie, M. L., Jayaram, S., Eisner, M., Sliemers, S., Pasley, K., McCoy, K., & Krivchenia, K. (2025). Edinburgh postnatal depression scale score elevation in caregivers of infants with cystic fibrosis. Pediatric Pulmonology, 60(1), e27364. https://doi.org/10.1002/ppul.27364
  4. Jayaram, S., Khuhro, A., Krivchenia, K., & Kalra, M. (2026). Frontal lobe epilepsy presenting as parasomnia in a child on BiPAP for severe obstructive sleep apnea. Sleep, 49(Supplement_1), A597. https://doi.org/10.1093/sleep/zsag091.1339

“`

Njeumi Felix | Epidemiology | Excellence in Research Award

Excellence in Research Award

Njeumi Felix
Food and Agriculture Organization of the United Nations
Academic Profile
Affiliation Food and Agriculture Organization of the United Nations
Country Italy
Scopus ID 6506444570
Documents 32
Citations 633
h-index 13
Subject Area Epidemiology
Event Global Diseases Research Awards

Njeumi Felix is an epidemiology researcher and international scientific coordinator associated with the Food and Agriculture Organization of the United Nations. His academic and professional activities are primarily connected to infectious disease surveillance, transboundary animal disease control, and global veterinary public health initiatives. His scholarly work reflects contributions to disease eradication programs, epidemiological assessment methodologies, and collaborative international research activities addressing livestock health management and sustainable agricultural development.[1][2]

Abstract

This academic recognition article provides a scholarly overview of Njeumi Felix and his contributions to epidemiology and infectious disease research. His professional activities include research coordination, epidemiological investigations, and participation in global veterinary health initiatives. His scientific work contributes to disease surveillance systems, veterinary public health frameworks, and collaborative international efforts addressing transboundary animal diseases and livestock health management.[1][3]

Keywords

Epidemiology; Veterinary Science; Infectious Diseases; Disease Surveillance; Peste des Petits Ruminants; Global Disease Eradication; Animal Health; Veterinary Public Health; Transboundary Diseases; International Research Collaboration.

Introduction

Epidemiological research plays a significant role in understanding infectious disease transmission and strengthening international disease prevention systems. Veterinary public health initiatives have become increasingly important due to the global impact of transboundary animal diseases on agricultural economies, livestock productivity, and food security. Njeumi Felix has contributed to these scientific and institutional efforts through research coordination, disease surveillance activities, and international collaborative programs.[2]

Research Profile

The research profile of Njeumi Felix reflects scholarly engagement in epidemiology, disease surveillance, and veterinary health management. His Scopus-indexed publication record includes research articles related to infectious disease risk analysis, surveillance strategies, vaccine assessment methodologies, and global disease control initiatives.[1]

Research Contributions

Njeumi Felix has contributed to research associated with Peste des Petits Ruminants and related transboundary animal diseases. His scientific involvement includes epidemiological modeling, disease risk mapping, surveillance frameworks, and international disease eradication planning activities.[3]

Publications

Selected scientific publications associated with Njeumi Felix include studies addressing epidemiological surveillance, disease risk analysis, vaccine evaluation, and transboundary disease management strategies.[3][4]

Research Impact

The scholarly impact of Njeumi Felix is reflected through citation metrics, collaborative publications, and continued participation in global disease research initiatives. His Scopus profile indicates a significant citation record and measurable academic influence within epidemiology and veterinary science research communities.[1]

Award Suitability

Njeumi Felix demonstrates suitability for recognition within the Global Diseases Research Awards due to his sustained contributions to epidemiology, veterinary public health, and infectious disease research. His scholarly activities reflect international collaboration, scientific productivity, and engagement with disease eradication initiatives relevant to global health priorities.[5]

Conclusion

Njeumi Felix has contributed to the advancement of epidemiological research and international veterinary health initiatives through collaborative scientific work and institutional engagement. His academic profile demonstrates ongoing involvement in disease surveillance, infectious disease management, and evidence-based veterinary public health strategies. The impact of his research supports recognition within scholarly platforms dedicated to global disease research and epidemiological studies.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Njeumi Felix, Author ID 6506444570. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6506444570
  2. Food and Agriculture Organization of the United Nations. (n.d.). Global animal health and disease control initiatives. FAO.
    https://www.fao.org/
  3. Arede, M., Beltrán-Alcrudo, D., Benfield, C., Casal, J., & Njeumi, F. (2024). Risk mapping of Peste des Petits Ruminants virus spread in nine countries surrounding the Black Sea: a spatial multicriteria decision analysis approach. Frontiers in Veterinary Science.
    https://doi.org/10.3389/fvets.2026.1783624
  4. Bodjo, C. S., et al. (2023). Peste des Petits Ruminants Vaccine: Criteria for Assessing Its Thermotolerance. Viruses.
    https://doi.org/10.3390/v17091151
  5. Global Diseases Research Awards. (n.d.). International academic recognition and disease research initiatives.
    https://globaldiseases.org/

Ting Cheng | Epidemiology | Research Excellence Award

Dr. Ting Cheng | Epidemiology | Research Excellence Award

Shanxi Medical University | China

Dr. Cheng Ting is a medical doctor and researcher affiliated with Shanxi Medical University, recognized for her contributions to autoimmune disease research, metabolic disorders, and chronic disease management. Her academic and clinical expertise spans rheumatology, endocrinology, osteoporosis, thyroid disorders, diabetes, and systemic autoimmune diseases. Dr. Cheng has actively contributed to translational medicine through clinical research projects and scientific publications focused on improving diagnosis, treatment, and patient outcomes. She has led provincial and hospital-level research projects and collaborated with national and international scientific communities. Her research achievements include SCI-indexed publications, academic book contributions, and patented medical innovations. Dr. Cheng has also gained international recognition through invited keynote lectures at major conferences, including EULAR and APLAR. Through her dedication to medical advancement, innovation, and patient-centered research, she continues to strengthen biomedical research and healthcare development both nationally and internationally.

Professional Profile

 

Education

Dr. Cheng Ting completed her medical education in China and earned her M.D. qualification with specialized training in internal medicine, autoimmune diseases, endocrinology, and chronic disease management. Her academic background provided extensive knowledge in clinical medicine, biomedical sciences, diagnostic methodologies, and evidence-based healthcare practices. During her advanced medical training, she developed strong expertise in rheumatology, osteoporosis research, metabolic diseases, and immune-related disorders. Her educational journey emphasized both theoretical medical sciences and practical clinical applications, enabling her to integrate patient care with scientific investigation. She further enhanced her academic profile through continuous participation in scientific conferences, professional workshops, and interdisciplinary medical collaborations. Her educational development also includes contributions to academic literature and participation in medical publishing activities. Through continuous learning and professional development, Dr. Cheng has established a strong academic foundation that supports her ongoing research in autoimmune diseases, metabolic health, chronic disease prevention, and translational clinical medicine.

Professional Experience

Dr. Cheng Ting has extensive professional experience in clinical medicine, biomedical research, and chronic disease management. She currently serves at Shanxi Medical University, where she combines patient care with advanced scientific research. Her clinical expertise includes the diagnosis and management of autoimmune diseases, osteoporosis, thyroid disorders, diabetes, and metabolic syndromes. Throughout her career, she has led two provincial and hospital-level research projects aimed at improving treatment strategies and healthcare outcomes. She has authored and co-authored several SCI-indexed research papers and contributed to multiple academic books related to medical sciences. Dr. Cheng also holds numerous national patents, reflecting her commitment to innovation and translational medicine. In addition to research and clinical responsibilities, she has been invited to present keynote speeches at internationally recognized conferences, including EULAR and APLAR. Her professional career demonstrates leadership, scientific excellence, and dedication to advancing global healthcare and medical research.

Research Interest 

Dr. Cheng Ting focuses her research on autoimmune diseases, metabolic disorders, rheumatology, endocrinology, and chronic disease prevention. Her studies investigate the mechanisms, diagnosis, and treatment strategies for conditions such as systemic sclerosis, osteoporosis, thyroid diseases, diabetes, and immune-mediated inflammatory disorders. She is particularly interested in translational medicine approaches that connect laboratory discoveries with clinical applications to improve patient outcomes. Her recent scientific contributions include research on viral infections and autoimmune diseases, as well as the clinical implications of nutritional interventions such as low-carbohydrate diets in autoimmune conditions. Dr. Cheng also emphasizes chronic disease management and preventive healthcare strategies aimed at reducing disease burden and improving long-term quality of life. Through multidisciplinary collaborations and evidence-based research methodologies, she continues to contribute to advancing biomedical science and precision medicine. Her research supports the development of innovative therapeutic approaches and improved healthcare systems for patients with autoimmune and metabolic disorders.

Awards and Honors

Dr. Cheng Ting has received several recognitions for her outstanding contributions to medical research, innovation, and healthcare advancement. One of her most notable achievements is receiving the Second Prize of the Shanxi Provincial Scientific and Technological Progress Award, which honors significant scientific contributions with practical healthcare impact. Her innovative work is further reflected in her ownership of 20 national patents related to medical technologies and healthcare solutions. Dr. Cheng has also earned professional recognition through invitations to deliver keynote speeches at major international and regional scientific conferences, including the European League Against Rheumatism (EULAR) and the Asia Pacific League of Associations for Rheumatology (APLAR). Her academic accomplishments include publishing multiple SCI-indexed papers and contributing to five academic books in the field of medicine and chronic disease management. These honors demonstrate her commitment to scientific innovation, translational medicine, clinical excellence, and international collaboration in biomedical and autoimmune disease research.

Conclusion

Dr. Cheng Ting  is a dedicated clinician, researcher, and innovator whose work significantly contributes to autoimmune disease research, metabolic medicine, and chronic disease management. With strong academic training, clinical expertise, research leadership, and international scientific engagement, she has established herself as an emerging contributor to biomedical and translational medicine. Her achievements include SCI-indexed publications, national patents, prestigious research awards, and keynote presentations at internationally recognized conferences. Dr. Cheng’s commitment to improving healthcare through scientific innovation and evidence-based medicine highlights her growing influence in global medical research. Her continued focus on interdisciplinary collaboration, translational medicine, and patient-centered healthcare positions her for further academic and professional excellence in the international biomedical research community.

Publications Top Noted

  • The application of low-carbohydrate diet in autoimmune diseases: Mechanisms, evidence, and prospects for clinical translation
    Authors: Ming-Fu Lu
    Citation: Autoimmunity Reviews | DOI: 10.1016/j.autrev.2026.104071
  •  Mendelian randomization unveils genetic causal relationships between viral infections and systemic sclerosis
    Authors: Ting Cheng
    Year: 2025
    Citation: Scientific Reports | DOI: Not provided

Daniel Lopez-Hernandez | Public Health | Research Excellence Award

Dr. Daniel Lopez-Hernandez | Public Health | Research Excellence Award

Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado | Mexico

Dr. Daniel López-Hernández is a researcher affiliated with the Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), Mexico, with expertise rooted in applied medical and health sciences that support evidence-based public health and clinical practice. He has authored 16 peer-reviewed publications, which together have received 361 citations, reflecting the relevance and visibility of his work within the scientific community. With an h-index of 7, his research demonstrates consistent scholarly impact and influence. Dr. López-Hernández has collaborated with over 40 co-authors, highlighting strong interdisciplinary and international research engagement. His contributions address real-world health challenges, strengthening healthcare delivery systems and informing policy and clinical decision-making. Through sustained research productivity and collaboration, his work contributes to improving health outcomes and advancing medical knowledge with tangible societal benefit.

Citation Metrics (Scopus Preview)

361
270
180
`16
0

Citations

361

Documents

16

h-index

7

Citations

Documents

h-index

Note: h-index details are disabled in Scopus Preview mode.

View Scopus Profile   View Google Scholar Profile
Top 5 Featured Publications

Huijun Guo | Prevention | Top HIV/AIDS Research Award

Prof. Huijun Guo | Prevention | Top HIV/AIDS Research Award

Henan University of Chinese Medicine | China

Prof. Huijun Guo is a scholar at Henan University of Chinese Medicine, Zhengzhou, China, with recognized expertise in infectious diseases, epidemiology, and evidence-based clinical research, particularly focused on HIV, chronic hepatitis B, Helicobacter pylori infection, and immune-related disorders. He has authored 54 Scopus-indexed publications, which have collectively received 272 citations, reflecting the steady academic influence of his work, and holds an h-index of 10. His research is characterized by high-impact systematic reviews, meta-analyses, and longitudinal cohort studies published in leading international journals such as BMJ Open, Frontiers in Medicine, and the World Journal of Gastroenterology. Prof. Guo has collaborated extensively with a broad international network of researchers, contributing to translational insights that inform clinical practice and public health policy. His work supports improved disease management strategies and strengthens evidence-based healthcare decision-making with clear societal relevance.

Citation Metrics (Scopus)

272
200
150
80
0

Citations

272

Documents

54

h-index

10

Citations

Documents

h-index

View Scopus Profile

Top 5 Featured Publications

Jin Hu | Public Health | Excellence in One Health Research

Dr. Jin Hu | Public Health | Excellence in One Health Research 

Tsinghua School of Medicine | China

Dr. Jin Hu is an Associate Professor at the Tsinghua School of Medicine, Beijing, China, with established expertise in biomedical and translational medical research. The author has published 14 peer-reviewed documents indexed in Scopus, receiving 985 citations and achieving an h-index of 12, reflecting consistent scholarly impact. Research contributions are recognized internationally through collaboration with 36 co-authors across interdisciplinary teams, supporting innovation in medical science and evidence-based healthcare. Hu Jin’s work advances scientific understanding with practical relevance, contributing to improved research capacity, knowledge dissemination, and long-term societal benefits in health and medicine at both national and global levels.

Citation Metrics (Scopus)

985
740
500
250
0

Citations

985

Documents

14

h-index

12

Citations

Documents

h-index

View Scopus Profile

Top 5  Featured Publications